US · guidance
CMS SOM App. M, Tag L700
§418.106(e)(3)(ii) Discrepancies in the acquisition, storage, dispensing,
administration, disposal, or return of controlled drugs must be investigated
immediately by the pharmacist and hospice administrator and where required
reported to the appropriate State authority. A written account of the
investigation must be made available to State and Federal officials if required by
law or regulation.
History
Rev. 210; Issued:02-03-23; Effective:02-03-23; Implementation:02-03-23
Provenance
- Source
- cms.gov
- Retrieved
- 2026-07-22
- Edition
- som-2026-07-22
- Content hash
66c326d6c2ab9e6206190be572132983dd7aa0dd7ca9c8dc701d68d7ed168fdf
The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.
Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.